Mechanism responsible for the decreased hepatic NADPH generation rate in rats with bilateral ureter ligation-induced renal failure

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 9, 2005, Pages 1809-1812

  Higashi, Takashi ^a   Urai, Misato ^a   Taguchi, Masato ^a   Hashimoto, Yukiya ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Bilateral ureter ligated rat; Bile duct ligated rat; NADPH generation; Pentose phosphate pathway

Indexed keywords

GLUCOSE 6 PHOSPHATE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; PENTOSE PHOSPHATE; PROPRANOLOL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FIRST PASS EFFECT; INTESTINE ABSORPTION; KIDNEY FAILURE; LIVER HOMOGENATE; LIVER METABOLISM; MALE; NONHUMAN; RAT; URETER LIGATION;

ANIMALS; CYTOSOL; GLUCOSE; KIDNEY FAILURE, ACUTE; KINETICS; LIGATION; LIVER; MALE; NADP; PENTOSE PHOSPHATE PATHWAY; RATS; RATS, INBRED STRAINS; RATS, WISTAR; URETER;

EID: 24944433047     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.28.1809     Document Type: Article

References (20)

1. Shand D. G., Rangno R. E., Pharmacology, 7, 159-168 (1972).
2. Laganiére S., Shen D. D., Nephron, 46, 305-311 (1987).
3. Walle T., Conradi E. C., Walle U. K., Fagan T. C., Gaffney T. E., Clin. Pharmacol. Ther., 24, 668-677 (1978).
4. Bianchetti G., Graziani G., Brancaccio D., Morganti A., Leonetti G., Manfrin M., Sega R., Gomeni R., Ponticelli C., Morselli P. L., Clin. Pharmacokinet., 1, 373-384 (1976).
5. Katayama H., Fujiwara J., Yasuhara M., Okumura K., Hori R., J. Pharmacobio-Dyn., 7, 536-544 (1984).
6. Terao N., Shen D. D., J. Pharmacol. Exp. Ther., 227, 295-301 (1983).
7. Hori R., Okumura K., Yasuhara M., Katayama H., Biochem. Pharmacol.,34, 2679-2683 (1985).
8. Terao N., Shen D. D., J. Pharmacol. Exp. Ther., 233, 277-284 (1985).
9. Okabe H., Mizukami A., Taguchi M., Aiba T., Yasuhara M., Hashimoto Y., J. Pharm. Pharmacol., 55, 479-486 (2003).
10. Okabe H., Higashi T., Ohta T., Hashimoto Y., Biol. Pharm. Bull., 27,1422-1427 (2004).
11. Okabe H., Hasunuma M., Hashimoto Y., Pharm. Res., 20, 1591-1594(2003).
12. Kurose M., Nippon Geka Gakkai Zasshi, 85, 457-467 (1984) (in Japanese).
13. Giacomini K. M., Roberts S. M., Levy G., J. Pharm. Sci., 70, 117-121 (1981).
14. Zhang Z., Yu J., Stanton R. C., Anal. Biochem., 285, 163-167 (2000).
15. Sanz N., Diez-Fernandez C., Valverde A. M., Lorenzo M., Benito M., Cascales M., Br. J. Cancer, 75, 487-492 (1997).
16. Stengård J. H., Saarni H. U., Stenback F., Keinanen K., Karki N. T., Sotaniemi E. A., Res. Commun. Chem. Pathol. Pharmacol., 50, 93-102 (1985).
17. Shafrir E., Brenner T., Gutman A., Orevi M., Am. J. Physiol., 226,162-167 (1974).
18. Szolkiewicz M., Sucajtys E., Chmielewski M., Wolyniec W., Rutkowski P., Boguslawski W., Swierczynski J., Rutkowski B., Horm. Metab. Res., 34, 234-237 (2002).
19. Touchette M. A, Slaughter R. L., DICP, 25, 1214-1224 (1991).
20. Yoshitani T., Yagi H., Inotsume N., Yasuhara M., Biol. Pharm. Bull.,25, 1077-1083 (2002).